BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:1696d317-7b4c-46c0-83be-4e0414ec55aa
DTSTAMP:20250731T104017
DTSTART:20251002T150000
DTEND:20251002T040000
SUMMARY:PK Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:da6bd3a4-2a6b-40e2-acbc-0308c39ac6aa
DTSTAMP:20250731T104017
DTSTART:20251007T100000
DTEND:20251007T110000
SUMMARY:PK Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:465cb403-7bda-4879-aef8-9d873d617816
DTSTAMP:20250731T104017
DTSTART:20251007T110000
DTEND:20251007T120000
SUMMARY:PK Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:1f77d12a-bf3d-4120-8973-4e0660ff5283
DTSTAMP:20250731T104017
DTSTART:20251007T120000
DTEND:20251007T010000
SUMMARY:PK Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:efda1f53-ad9c-47ba-ae96-6a7a4b575d72
DTSTAMP:20250731T104017
DTSTART:20251017T150000
DTEND:20251017T040000
SUMMARY:Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:b953a883-8a04-40fe-9554-659ad333b5b0
DTSTAMP:20250731T104017
DTSTART:20251021T100000
DTEND:20251021T110000
SUMMARY:PK  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:84bee0f5-bb72-454d-b9fe-408079f8fe57
DTSTAMP:20250731T104017
DTSTART:20251027T100000
DTEND:20251027T110000
SUMMARY:PK Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:7e92c6d6-f9be-4fb7-86c3-58bf7db9f832
DTSTAMP:20250731T104017
DTSTART:20251027T110000
DTEND:20251027T120000
SUMMARY:PK Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:89e9f590-e87b-408e-bf0a-c7621ea2ff4e
DTSTAMP:20250731T104017
DTSTART:20251027T120000
DTEND:20251027T010000
SUMMARY:PK Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:7129bac0-9fd9-4b7a-a378-05f8deaa22c8
DTSTAMP:20250731T104017
DTSTART:20251030T120000
DTEND:20251030T010000
SUMMARY:Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:fd5cd1db-1cd9-44f6-ae5b-a321c2137c56
DTSTAMP:20250731T104017
DTSTART:20251030T140000
DTEND:20251030T030000
SUMMARY:PK study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:5b4f51f1-96d8-4dbf-9a2c-8af88f0e333e
DTSTAMP:20250731T104017
DTSTART:20251030T150000
DTEND:20251030T040000
SUMMARY:PK study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:d5c2497a-ad5d-4f26-b9ee-a09eb81d4c73
DTSTAMP:20250731T104017
DTSTART:20251113T100000
DTEND:20251113T110000
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:4a123efb-b334-49a9-a9b1-0a0bdef0a100
DTSTAMP:20250731T104017
DTSTART:20251113T110000
DTEND:20251113T120000
SUMMARY:PK Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:b83d20b6-dc5e-46ee-8f29-a4ace9d9a235
DTSTAMP:20250731T104017
DTSTART:20251113T120000
DTEND:20251113T010000
SUMMARY:PK Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:0775044a-9da8-4de9-9606-1bc70ac6c379
DTSTAMP:20250731T104017
DTSTART:20251205T140000
DTEND:20251205T030000
SUMMARY:Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:5061e79b-bbd0-4fb4-8b6e-053eb900d3f3
DTSTAMP:20250731T104017
DTSTART:20251208T100000
DTEND:20251208T110000
SUMMARY:PK Pharmacokinetic Variability and Assignment Debrief
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Reya, Ateeq, Dan
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:1440b6ad-e2d2-4f4b-be4e-cb3f607d7a96
DTSTAMP:20250731T104017
DTSTART:20260108T140000
DTEND:20260108T030000
SUMMARY:PK.  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:934488f0-f933-41f6-9007-286535538ae4
DTSTAMP:20250731T104017
DTSTART:20260108T150000
DTEND:20260108T040000
SUMMARY:PK.  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:
END:VEVENT
END:VCALENDAR
